Peripheral neural targets in obesity
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Interest in pharmacological treatments for obesity that act in the brain to reduce appetite has increased exponentially over recent years, but failures of clinical trials and withdrawals due to adverse effects have so far precluded any success. Treatments that do not act within the brain are, in contrast, a neglected area of research and development. This is despite the fact that a vast wealth of molecular mechanisms exists within the gut epithelium and vagal afferent system that could be manipulated to increase satiety. Here we discuss mechano‐ and chemosensory pathways from the gut involved in appetite suppression, and distinguish between gastric and intestinal vagal afferent pathways in terms of their basic physiology and activation by enteroendocrine factors. Gastric bypass surgery makes use of this system by exposing areas of the intestine to greater nutrient loads resulting in greater satiety hormone release and reduced food intake. A non‐surgical approach to this system is preferable for many reasons. This review details where the opportunities may lie for such approaches by describing nutrient‐sensing mechanisms throughout the gastrointestinal tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Weight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808 · cited 1×
“Most developed societies are experiencing an epidemic of obesity and its closely related co-morbidity type 2 diabetes (Chan et al., 1994; Colditz et al., 1995).”
BackgroundInhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 2×
“Despite this generalized attenuation in GI peptide release, the anorectic effects of exogenously administered CCK, PYY and GLP-1 appear to be preserved in obese individuals (Flint et al., 2001; Batterham et al., 2003).”
BackgroundSamuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Long-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449 · cited 1×
“Very recent evidence suggests that increased drive to eat upon dieting is a result of decreased gut hormone release, rather than being entirely a psychological phenomenon (Sumithran et al., 2011).”
BackgroundGastrointestinal regulation of food intake
Cummings, D. E., & Overduin, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30227 · Cited by 1,216 · cited 4×
“Cholecystokinin CCK-secreting I-cells are located largely within the proximal small intestine and are more responsive to digestion products of fatty and amino acids than to carbohydrates (Rehfeld, 1978; Cummings and Overduin, 2007).”
BackgroundInfluentialGut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.
Jang, H.-J., Kokrashvili, Z., Theodorakis, M. J., Carlson, O. D., Kim, B.-J., Zhou, J., Kim, H. H., Xu, X., Chan, S. L., Juhaszova, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706890104 · Cited by 995 · cited 2×
“…been shown that blockade of sweet taste receptors reduces glucose-stimulated GLP-1 [and peptide YY (PYY)] release, while mice that are deficient in sweet taste molecule expression show dysregulated glucose-stimulated GLP-1 release (Jang et al., 2007; Margolskee et al., 2007; Gerspach et al., 2011).”
BackgroundInhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963 · cited 1×
“There is recent interest in GIP in the obesity setting, given that GIP knockout mice are resistant to dietinduced obesity (Miyawaki et al., 2002).”
BackgroundT1R3 and gustducin in gut sense sugars to regulate expression of Na + -glucose cotransporter 1
Margolskee, R. F., Dyer, J., Kokrashvili, Z., Salmon, K. S. H., Ilegems, E., Daly, K., Maillet, E. L., Ninomiya, Y., Mosinger, B., & Shirazi-Beechey, S. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706678104 · Cited by 882 · cited 2×
“…been shown that blockade of sweet taste receptors reduces glucose-stimulated GLP-1 [and peptide YY (PYY)] release, while mice that are deficient in sweet taste molecule expression show dysregulated glucose-stimulated GLP-1 release (Jang et al., 2007; Margolskee et al., 2007; Gerspach et al., 2011).”
Background
Cited by
Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
Furness, J. B., Rivera, L. R., Cho, H.-J., Bravo, D. M., & Callaghan, B. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.180 · Cited by 526
Val-Laillet, D., Aarts, E., Weber, B., Ferrari, M., Quaresima, V., Stoeckel, L. E., Alonso-Alonso, M., Audette, M., Malbert, C. H., & Stice, E. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.03.016 · Cited by 442
The metabolic role of vagal afferent innervation
Waise, T. M. Z., Dranse, H. J., & Lam, T. K. T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0062-1 · Cited by 140
Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology
Browning, K. N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00413 · Cited by 138
“…the integration of “higher” CNS centers with autonomic nuclei, the role of vago-vagal neurocircuits in the regulation of early satiety signaling has been the subject of renewed attention by several laboratory groups (Page et al., 2012; Dockray, 2013; de Lartigue, 2014; Kentish and Page, 2014).”
Background
Metadata
- Authors
- Page, A. J., Symonds, E., Peiris, M., Blackshaw, L. A., & Young, R. L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-06-21
- Volume
- 166
- Issue
- 5
- Pages
- 1537-1558
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1606110752
- Cited by
- 43
- References
- 41
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral neural targets in obesity. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.01951.x
- The paper
- Page, A. J., Symonds, E., Peiris, M., Blackshaw, L. A., & Young, R. L. (2012). Peripheral neural targets in obesity. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.01951.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.